A modified protocol for the preparation of botulinum type A toxic crystals is described. The essential change was the substitution of chromatography on diethylaminoethyl-Sephadex for the step in which toxin was precipitated with ethanol. Colored materials and nucleic acids were removed by the chromatography so that crystal lots of greater uniformity could be produced. Significantly more of the toxin in the starting culture was recovered as crystals. The lots of crystals obtained initially by either the original or the modified method contained an antigen that was eliminated when the lots were recrystallized.
A modified protocol for the preparation of botulinum type A toxic crystals is described. The essential change was the substitution of chromatography on diethylaminoethyl-Sephadex for the step in which toxin was precipitated with ethanol. Colored materials and nucleic acids were removed by the chromatography so that crystal lots of greater uniformity could be produced. Significantly more of the toxin in the starting culture was recovered as crystals. The lots of crystals obtained initially by either the original or the modified method contained an antigen that was eliminated when the lots were recrystallized.
Crystallization of Clostridium botulinum type A toxin by different procedures was first reported in 1946 (1, 5, 7) , but the protocol developed in 1957 by Duff et al. (4) is the present choice for preparing the neurotoxic crystals. The crystals are not pure toxin: they are molecular complexes in which the neurotoxin protein is noncovalently associated with a nontoxic protein with hemagglutinating activity (3, 6) and probably with a second nontoxic protein that is not a hemagglutinin (10) . The nontoxic and toxic proteins are antigenically distinct.
Because they are relatively easy to produce in quantity and toxin in this form is stable, these crystals have been used for many purposes; e.g., neurotoxin is usually purified from crystal stocks (3, 12) . However, the crystalline preparations vary in quality: the different preparations may be colorless to various straw shades, and an absorbance ratio (A260/A278) range of near 0.5 to 0.7 or higher indicates differing nucleic acid content (9 A culture stock of the C. botulinum type A Hall strain (4) was grown in cooked-meat medium (Difco) for 2 days and stored at -20°C. For toxin production, about 1.0 ml of thawed stock culture was transferred into a tube containing 30 ml of cooked-meat medium. After overnight incubation, when active gassing indicated good growth, the fluid portion of the culture was decanted aseptically into a 1-liter flask containing 600 ml of freshly prepared toxin production medium. When this culture reached the middle to late logarithmic growth phase, the entire volume was seeded into a bottle of toxin production medium that had been prepared the previous day. Incubations were at 37°C; no special precaution was used for developing anaerobic conditions.
Crystallization of toxic complex. Hemagglutination tests. Erythrocytes in an outdated human blood bank sample were made as a 0.5% suspension in 0.075 M phosphate buffer-0.075 M NaCl (pH 7.4) after three washes with the buffer. In the microtitration, 0.05 ml of cell suspension was added to the same volume of sample dilutions made serially in twofold increments with the phosphate saline. Tests were read after 4 h at room temperature. Figure 1 illustrates a typical result obtained in the DEAE-Sephadex chromatography. The APPL. ENVIRON. MICROBIOL. first protein peak (pool 1) contained most of the applied toxicity; the second pool had about 5% and was discarded. Treatment of the sample with ribonuclease before chromatography was not always needed, but chromatographic behavior was more consistent when the step was included. The first few fractions containing protein sometimes had an A260/A278 ratio of 0.6 or higher. Such fractions were not included in the toxin pool without meaningfully affecting toxin recovery, because their toxin content was low. The toxic pools to be processed for crystals were colorless and had A26,0A278 ratios of 0.54 or lower.
RESULTS AND DISCUSSION
Results at several purification stages during processing of three separate 16-liter culture lots are averaged in Table 1 . The 33% recovery of starting toxicity in crystals was nearly twice the 17% reported for the original procedure (4). The higher recovery came at the crystallization step; of the toxin in the DEAE-Sephadex toxic pool, 80% crystallized as compared with 42% of the toxin in the extract of the ethanol-precipitated preparations. The more complete crystallization may be a result of the chromatographed samples having less materials that interfered with crystal formation; when crystals obtained by the procedure of Duff et al. were dissolved, proportionately more of the toxin present was recovered during recrystallization than during the original crystallization. Maximum recovery of crystals from the ethanoltreated samples required several months, whereas crystallization in the chromatographed sample was completed in about 3 weeks.
The A278 of the samples to be chromatographed varied, but column overloading was not encountered so long as the volume/volume ratio of the sample to the DEAE-Sephadex bed did not exceed that cited in the processing of the 16-liter culture (legend, Fig. 1 ). Satisfactory results were obtained when the toxic extract from 64 liters of culture was chromatographed on a column (5.0 by 75 cm). Regeneration of the resin was easier if the intensely colored top 1 or 2 cm of the gel column was discarded.
Crystalline preparations obtained with the chromatographic step had toxic and hemagglutinating activities comparable to those obtained by the original method. The specific toxicity range of 3.0 x 107 to 3.7 x 107 LD50/mg Of protein was that expected of crystalline preparations (9) . All samples caused hemagglutination at a concentration of 0.4 ,ug/ml.
Although the actual results were unexpected, crystals developed by the two methods had similar antigenic compositions. In the double-diffusion serology with anticrystalline serum, all crystalline preparations obtained by the original and modified procedures had three common antigens (Fig. 2) instead of the two (neurotoxin and hemagglutinin) expected (3) .
When the antigens were reacted against antineurotoxin, only one immune precipitate line developed. Since the third antigen, which was much lower in amount than the other two, was absent from 2 x -recrystallized preparations, it was probably a contaminant. 
